by Sue Robbins | Mar 2, 2020 | Migraine
In the book “Migraine: A History” (Johns Hopkins University Press), medical historian Katherine Foxhall writes of a disabling disease that has been documented going back thousands of years, though the causes of this neurological disorder are still unclear....
by Sue Robbins | Feb 28, 2020 | Migraine
NEW HAVEN, Conn., Feb. 27, 2020 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today announced that the U.S. Food and Drug Administration (FDA) has approved Nurtec ODT (rimegepant) for the acute treatment of migraine in adults. Nurtec...
by Sue Robbins | Feb 27, 2020 | Migraine
Patients with psoriasis are at increased risk for migraines, according to a research letter published in the Journal of the American Academy of Dermatology. Researchers from the New York University School of Medicine examined data obtained from the 2003-2004 National...
by Sue Robbins | Feb 26, 2020 | Wellness
Reading the news can be stress-inducing at the best of times. When the news is particularly worrying, many of us experience levels of anxiety so high that we can have difficulty coping. So how can we stay (reasonably) anxiety-free when the media bombards us with...
by Sue Robbins | Feb 25, 2020 | Migraine
The United States Food and Drug Administration (US FDA) has just approved Vyepti™ for the preventive treatment of migraine. Vyepti (eptinezumab-jjmr) will be the first intravenous (IV) preventive treatment on the market for migraine disease. It will be available...
